Wells Fargo
IART icon

Wells Fargo’s Integra LifeSciences IART Stock Holding History

Wells Fargo’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,000
Closed -$16K – 6515
2020
Q1 		$16K Buy
+1,000
New +$52.5K ﹤0.01% 5649

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wells Fargo's IART Position: Q1 2026 in Review

Wells Fargo reduced its Integra LifeSciences (IART) stake by 59% in Q1 2026, selling an estimated $507K and leaving 32,360 shares worth $305K. The position accounts for ﹤0.01% of the portfolio, ranked #4440.

Wells Fargo first reported a position in IART in Q2 2013 and has held it in 52 quarters since. The position peaked at $179M in Q4 2016. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Wells Fargo held 32,360 shares of Integra LifeSciences worth $305K as of Q1 2026.
  • Wells Fargo sold 46,174 Integra LifeSciences shares in Q1 2026, an estimated $507K.
  • Integra LifeSciences made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4440 holding.
  • Wells Fargo first reported a position in Integra LifeSciences in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's Integra LifeSciences position peaked at $179M in Q4 2016.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.